Eur J Nucl Med Mol Imaging (2017) 44:1671–1678 DOI 10.1007/s00259-017-3756-7 ORIGINAL ARTICLE Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer 1 2 3 4 5 Yong Du & Ignasi Carrio & Giuseppe De Vincentis & Stefano Fanti & Harun Ilhan & 6 7 8 9 Caroline Mommsen & Egbert Nitzsche & Francis Sundram & Wouter Vogel & 1,10 11 Wim Oyen & Val Lewington Received: 2 June 2017 /Accepted: 7 June 2017 /Published online: 19 June 2017 The Author(s) 2017. This article is an open access publication Abstract UK) experienced in administering radium-223. The findings Purpose Radium Ra 223 dichloride (radium-223, Xofigo®) were collated and discussed at a meeting of experts from these is the first targeted alpha therapy for patients with castration- centres, during which key consensus recommendations were resistant prostate cancer and symptomatic bone metastases. defined. Radium-223 provides a new treatment option for this setting, Results The recommendations cover centre organization and but also necessitates a new treatment management approach. preparation; patient referral; radium-223 ordering, preparation We provide straightforward and practical recommendations and disposal; radium-223 treatment delivery/administration; for European nuclear medicine centres to optimize radium- and patient experience. Guidance includes structured coordi- 223 service provision.
European Journal of Nuclear Medicine and Molecular Imaging – Springer Journals
Published: Jun 19, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera